Skip to main content
OpenTrials

Clinical trial condition

Herpesviridae Infections

Explore clinical trials studying Herpesviridae Infections. Study availability and eligibility vary by location and protocol.

1,824 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Herpesviridae Infections trial results

Completed

Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older

NCT01165177

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 274 locations
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00004031

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations
  • Oregon Health & Science University Portland, Oregon, United States
  • Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute at University of Alberta Edmonton, Alberta, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View all 15 locations
View Trial Details
Completed

Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)

NCT03239873

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +4 more
Locations
  • Alabama Clinical Therapeutics ( Site 0018) Birmingham, Alabama, United States
  • Children's Clinic of Jonesboro, PA ( Site 0030) Jonesboro, Arkansas, United States
  • Southland Clinical Research Center ( Site 0017) Anaheim, California, United States
  • Premier Health Research Center, LLC ( Site 0044) Downey, California, United States
View all 37 locations
View Trial Details
Completed

Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults

NCT03382405

Conditions
Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations
  • Research Centers of America Hollywood, Florida, United States
  • Advanced Clinical Research Meridian, Idaho, United States
  • Optimal Research Peoria, Illinois, United States
  • Johnson County Clinical Trials Lenexa, Kansas, United States
View Trial Details

Related conditions